Anterior Juxtascleral Delivery of Anecortave Acetate in Eyes with Primary Open-Angle Glaucoma: A Pilot Investigation
-
Add time:07/23/2019 Source:sciencedirect.com
PurposeTo describe the intraocular pressure (IOP)-lowering effects in eyes with open-angle glaucoma (OAG) after treatment with an anterior juxtascleral depot of anecortave acetate.
We also recommend Trading Suppliers and Manufacturers of ANECORTAVE ACETATE RELATED COMPOUND A (20 MG) (9(11 )-DEHYDROCORTISOL) (cas 10184-70-0). Pls Click Website Link as below: cas 10184-70-0 suppliers
Prev:Anecortave Acetate (15 Milligrams) versus Photodynamic Therapy for Treatment of Subfoveal Neovascularization in Age-Related Macular Degeneration
Next:The excluded 3-minors for vf-safe delta-matroids) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Anecortave Acetate (15 Milligrams) versus Photodynamic Therapy for Treatment of Subfoveal Neovascularization in Age-Related Macular Degeneration07/22/2019
- Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration07/20/2019
- Pharmacokinetics and Metabolism of Anecortave Acetate in Animals and Humans07/21/2019
- Preclinical Efficacy of Anecortave Acetate07/19/2019
-
Health and Chemical more >
-
Related Products


